AMERSA

AMERSA

Call Us: (401) 615-4047 | Contact Us AMERSA on Twitter AMERSA on LinkedIn AMERSA on BlueSky

Make a Donation Pay a Past-Due Balance Join Our Mailing List
  • About
    • What is AMERSA
    • Board of Directors
    • Donate to AMERSA
    • Contact Us
  • Membership
    • Get to Know AMERSA
    • Join / Renew
    • Who We Are
    • Member Center
    • Special Interest Groups
    • Career Opportunities
    • Professional & Academic Advancement Opps
  • Conference
    • Annual Conference
    • Conference Sponsorship
    • Conference Exhibitor Information
    • Policy and Procedures for AMERSA Events
    • 2024 Conference Materials
    • Past Conference Resources
  • Journal
    • Journal Home
    • About Us
    • Member Access to Journal
    • Author Instructions and Submission
    • SAj Blog
    • SAj Annual Awards
    • SAj Editorial Scholar Program
  • Advocacy
    • AMERSA Advocacy
    • Position Statements
    • Submit a Position Statement
    • Letters of Support
    • Public Comments
  • Sustainability
    • Initiatives
    • Resources
  • Education
    • AMERSA Podcast Series
    • AMERSA Webinars
    • Core Competencies – AMERSA in the 21st Century
    • Resources
  • Awards
    • AMERSA Awards
    • Current Award Winners
    • Past Award Winners

The Authors’ Own Words: The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain

Jan 11, 2017 by AMERSA

We ask authors to describe their impressions regarding the implications of their accepted work, how their findings will change practice, and what is noteworthy about the work.

The association between benzodiazepine prescription and aberrant drug-related behaviors in primary care patients receiving opioids for chronic pain
Tae Woo Park, Richard Saitz, Kerrie P. Nelson, Ziming Xuan, Jane M. Liebschutz, and Karen E. Lasser
Substance Abuse Vol. 37 , Iss. 4,2016

We found that benzodiazepine prescription was associated with early opioid refills in patients prescribed opioids for pain. An important part of a clinician’s role is to weigh the risks and benefits of a treatment. We feel that this study can help clinicians who treat chronic pain patients with opioids in making that risk-benefit calculation before prescribing a benzodiazepine by providing more information about the potential risks of benzodiazepine use in this population.

—————————————————————————————————–
Our newly released issue is now online —> October-December 2016.
—————————————————————————————————–

Filed Under: SAj Blog, The Authors' Own Words

Copyright © 2025
Site by: web360